Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 302 clinical trials
Featured trial
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

moderate-to-severe COPD Evaluate the efficacy of itepekimab compared with placebo on corticosteroid-treated AECOPD in former smokers with moderate-to-severe COPD Evaluate the efficacy of

  • 467 views
  • 05 Jul, 2022
  • 55 locations
Featured trial
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

damaged, causing painful mouth sores. Dexamethasone is a corticosteroid that is commonly used to treat inflammation. It is the only corticosteroid available that can be used as a mouth rinse.

graft versus host disease
graft-versus-host disease
  • 160 views
  • 22 Dec, 2020
  • 1 location
Featured trial
GRAVITAS-309: A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).  

graft versus host disease
graft-versus-host disease
  • 119 views
  • 10 May, 2022
  • 1 location
Featured trial
A 30-day study evaluating a topical corticosteroid spray.

A 30-day study evaluating a topical corticosteroid spray.

  • 207 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and adult patients with persistent asthma.

A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and

  • 254 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors

  • 60 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps

To evaluate the efficacy of CBP-201 in patients with chronic rhinosinusitis with nasal polyps 

nasal polyps
rhinosinusitis
  • 0 views
  • 07 Mar, 2022
  • 1 location
Featured trial
Have you been diagnosed with Asthma?

Have you been diagnosed with Asthma?

  • 308 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Longitudinal Observational Study of Severe Asthma

Background: Asthma is a lung condition that causes difficulty breathing and decreased lung function. Some people with asthma have more severe disease symptoms. They may be less responsive to standard treatments such as steroids. Researchers want to compare severe asthmatics with mild or moderate asthmatics or people without asthma over …

asthmatic
allergic asthma
asthma
  • 22 views
  • 22 Dec, 2020
  • 1 location
Featured trial
A phase III randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of lebrikizumab in patients with persistent moderate to severe atopic dermatitis that is inadequately controlled by topical corticosteroids

A phase III randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of lebrikizumab in patients with persistent moderate to severe atopic dermatitis that is inadequately controlled by topical corticosteroids

  • 202 views
  • 08 Nov, 2020
  • 1 location